I've just had a quick look at the announcements around this time...

I've just had a quick look at the announcements around this time last year - it's quite depressing really.
Firstly there was no CC with the April 4C...

But, apart from that what a difference a year makes

This time last year, we had a lot of exciting news and everything was looking promising.
This year, in April so far - no news.

C'mon Mesoblast - organise a CC with the April quarterly and give us the landscape.
Even if there's nothing official to announce - just explain what is being worked on and the progress/ challenge relating to each of these big ticket items:

1. Ryoncil
2. C19 ARDS
3. Novartis
4. CHF data, partnerships - existing and any new developments
5. CLBP data, partnerships - existing and any new developments
6. SurgeCenter - provide a bit more details - why did they invest etc

I'm a huge supporter of Mesoblast and still live in hope - but, I need some explanations.
As the silence has been deafening

The SP performance only exacerbate this negativity